This chart shows the pharmaceutical companies with the most patents in Russian Federation. Patents must be filed in each country (or, in some cases regional patent office) where patent protection…
The post Which pharmaceutical companies have the most d…
Which pharmaceutical companies have the most drug patents in Russian Federation? Read Post »
Annual Drug Patent Expirations for ENVARSUS+XR Envarsus Xr is a drug marketed by Veloxis Pharms Inc and is included in one NDA. It is available from one supplier. There are…
The post New patent for Veloxis Pharms drug ENVARSUS XR appeared first on Drug…
Annual Drug Patent Expirations for RYANODEX Ryanodex is a drug marketed by Eagle Pharms and is included in one NDA. It is available from one supplier. There are five patents…
The post New patent for Eagle Pharms drug RYANODEX appeared first on DrugPate…
Annual Drug Patent Expirations for LEVAQUIN Levaquin is a drug marketed by Janssen Pharms and is included in three NDAs. There is one patent protecting this drug and one Paragraph…
The post New patent expiration for Janssen Pharms drug LEVAQUIN appeare…
New patent expiration for Janssen Pharms drug LEVAQUIN Read Post »
This chart shows the drugs with the most patents in South Korea. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical drugs have the most drug patents in South Korea?…
Which pharmaceutical drugs have the most drug patents in South Korea? Read Post »
LEVAQUIN (levofloxacin) Janssen pharms Patent: 6,806,256 Expiration: Aug 26, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug …
Drug Patent Expirations for the Week of August 21, 2022 Read Post »
Annual Drug Patent Expirations for FINTEPLA Fintepla is a drug marketed by Zogenix Inc and is included in one NDA. It is available from one supplier. There are eleven patents…
The post New patent for Zogenix Inc drug FINTEPLA appeared first on DrugPate…
Annual Drug Patent Expirations for QINLOCK Qinlock is a drug marketed by Deciphera Pharms and is included in one NDA. There are seven patents protecting this drug. This drug has…
The post New patent for Deciphera Pharms drug QINLOCK appeared first on D…
Annual Drug Patent Expirations for CABENUVA+KIT Cabenuva Kit is a drug marketed by Viiv Hlthcare and is included in one NDA. It is available from one supplier. There are five…
The post New patent for Viiv Hlthcare drug CABENUVA KIT appeared first on Dr…
Annual Drug Patent Expirations for SCEMBLIX Scemblix is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There is one patent protecting…
The post New patent for Novartis drug SCEMBLIX appeared first on DrugPate…
Get new actionable insights and updates from BiotechBlog
